Novel Serum Biomarkers to Differentiate Cholangiocarcinoma from Benign Biliary Tract Diseases Using a Proteomic Approach. - Wikidata - wikimedia - TriplyDB

Novel Serum Biomarkers to Differentiate Cholangiocarcinoma from Benign Biliary Tract Diseases Using a Proteomic Approach.

Novel Serum Biomarkers to Differentiate Cholangiocarcinoma from Benign Biliary Tract Diseases Using a Proteomic Approach.

http://www.wikidata.org/entity/Q35594611

about

An Omics Perspective on Molecular Biomarkers for Diagnosis, Prognosis, and Therapeutics of Cholangiocarcinoma Gene Expression and Proteome Analysis as Sources of Biomarkers in Basal Cell Carcinoma From Normal Skin to Squamous Cell Carcinoma: A Quest for Novel Biomarkers Next-generation sequencing traces human induced pluripotent stem cell lines clonally generated from heterogeneous cancer tissue.Characterization of Gene Expression Patterns among Artificially Developed Cancer Stem Cells Using Spherical Self-Organizing Map.Serum and tissue markers in hepatocellular carcinoma and cholangiocarcinoma: clinical and prognostic implications Advances in mass spectrometry-based cancer research and analysis: from cancer proteomics to clinical diagnostics.Direct Assessment of Plasma/Serum Sample Quality for Proteomics Biomarker Investigation.FAM19A5, a brain-specific chemokine, inhibits RANKL-induced osteoclast formation through formyl peptide receptor 2.Translational Bioinformatics for Cholangiocarcinoma: Opportunities and Challenges.

P2860

Q26784091-21B2DAE9-A000-498F-A781-834DD779E796 Q28074335-752B6675-F2D1-459B-BCBB-BC56F1A91CCB Q28078702-2D20312B-2058-41E4-8098-D1A1EEC36779 Q33716184-51893330-F51E-42BF-9632-48FADB5C1FFF Q37183311-76C89FFB-1C3D-4D43-BDA8-B6E35C5512FE Q37706763-36F8E725-FC97-4570-B5D8-C2A02C8C4FC1 Q38816181-08D77C83-A5A4-4D8F-924B-E26BF218F563 Q39413046-8D7AFA83-5FA4-4CAF-B889-9D3302966210 Q46943837-710004A0-0DBD-44C5-96BA-80BA049FBFC3 Q55513254-BE4511F0-4929-4A68-A72B-A27E95E50DD3

P2860

Novel Serum Biomarkers to Differentiate Cholangiocarcinoma from Benign Biliary Tract Diseases Using a Proteomic Approach.

http://www.wikidata.org/entity/Q35594611

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Novel Serum Biomarkers to Diff ...... es Using a Proteomic Approach.

@ast

Novel Serum Biomarkers to Diff ...... es Using a Proteomic Approach.

@en

type

label

Novel Serum Biomarkers to Diff ...... es Using a Proteomic Approach.

@ast

Novel Serum Biomarkers to Diff ...... es Using a Proteomic Approach.

@en

prefLabel

Novel Serum Biomarkers to Diff ...... es Using a Proteomic Approach.

@ast

Novel Serum Biomarkers to Diff ...... es Using a Proteomic Approach.

@en

P1433

Q35594611-5586E057-02B8-4C75-B59E-9A770F75CA2B

P1476

Q35594611-B4FDAE64-933F-4B6D-88D7-2FBF304E84CD

P2093

Q35594611-359E9C59-8317-4FBD-B95F-35FBC1143067

Q35594611-86EC1F0A-EF6C-461F-A54A-4B785DAB537A

P2860

Q35594611-070FD84B-FF18-4D95-9E1B-5557917F37D4

Q35594611-1738C0C4-EADD-4807-BEDE-CA49D42579C1

Q35594611-1CE4DF6E-DFF5-46B0-92D1-03AFA53AC3CD

Q35594611-26C29C79-672A-4192-8706-AEA84CE4C4E4

Q35594611-36C059EE-433A-4EAD-B4C1-797480319C3C

Q35594611-3FFF3572-1BC2-4DD3-B67A-E0B880C4AB0F

Q35594611-408B2FC5-5EBB-4621-900F-32F77B1C364A

Q35594611-484B3E04-B324-4B66-BF3E-F218E4968162

Q35594611-4BFC9A19-3ACE-4469-8E04-D807A0CE3009

Q35594611-587C2135-CF57-4019-9EBF-2B89C021C69D

P304

Q35594611-54D5E94C-FC05-4564-A951-FC125F656676

P31

Q35594611-ED379F54-194B-4F02-A7B7-DFC89339DBC9

P356

Q35594611-34F69E87-A27B-4CEB-9E1B-BED9741A81A4

P478

Q35594611-E2C5D466-8652-42FA-A674-FEB7BA299CD8

P50

Q35594611-0B71BA94-2EDD-4BA3-9BC2-C868F9CD26C4

Q35594611-347C3D3E-A608-4FCA-A8B0-AE765EC0B0F4

Q35594611-68EFB8F9-3D57-4F8B-8607-D50251293281

P577

Q35594611-F542C2BA-1918-4C5B-B62E-101D2972A268

P5875

Q35594611-5CA32BC0-A41D-4620-BA4B-7F9061770018

P698

Q35594611-D7DD2E1C-716F-4563-B24D-B87842CDC96F

P921

Q35594611-7DE92CBA-B53F-4786-9D98-9AF0DF5D8DC2

P932

Q35594611-8F0FE49E-2302-497A-8517-0D7054135862

P356

P1433

Disease Markers

P1476

Novel Serum Biomarkers to Diff ...... ses Using a Proteomic Approach

@en

P2093

Kawin Leelawat

http://www.w3.org/2001/XMLSchema#string

Sittiruk Roytrakul

http://www.w3.org/2001/XMLSchema#string

P2860

Cloning and characterization of a novel Kruppel-associated box family transcriptional repressor that interacts with the retinoblastoma gene product, RB

STRING v9.1: protein-protein interaction networks, with increased coverage and integration

TM4 microarray software suite

Diagnosis of cholangiocarcinoma.

Quantitative proteomics and biomarker discovery in human cancer

Transcriptome analysis identifies TNF superfamily receptors as potential therapeutic targets in alcoholic hepatitis.

Immunohistochemical expression of mismatch repair genes: a screening tool for predicting mutator phenotype in liver fluke infection-associated intrahepatic cholangiocarcinoma.

The utility of CA 19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis.

The value of serum CA 19-9 in predicting cholangiocarcinomas in patients with primary sclerosing cholangitis.

Cholangiocarcinoma: lessons from Thailand

P304

105358

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2015/105358

http://www.w3.org/2001/XMLSchema#string

P478

2015

http://www.w3.org/2001/XMLSchema#string

P50

Tavan Janvilisri

Atchara Paemanee

Rutaiwan Tohtong

P577

2015-04-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

276127491

http://www.w3.org/2001/XMLSchema#string

P698

26060332

http://www.w3.org/2001/XMLSchema#string

P921

cholangiocarcinoma

P932

4427802

http://www.w3.org/2001/XMLSchema#string